Related Experiment Video
Updated: Aug 5, 2026
A Protein Microarray Assay for Serological Determination of Antigen-specific Antibody Responses Following Clostridium difficile Infection
Published on: June 15, 2018
Nonthyroidal Illness Syndrome in Clostridium Difficile Infections Predict Mortality
Aleksandra Młodożeniec1, Martyna Mendyka1, Anna Watras1
1Clinic of Internal Medicine, Nephrology and Endocrinology with Nuclear Medicine Laboratory and Dialysis Center, State Hospital 2, Rzeszów, Poland.
Introduction:
Clostridium difficile infections (CDIs) are among the most common causes of hospital diarrhea and are associated with prolonged hospitalization and increased mortality.
Aim:
To evaluate the prevalence of nonthyroidal illness syndrome (NTIS) in hospitalized patients with CDI and its impact on the length of hospitalization and patient survival.
Methods:
A retrospective single-center study at a hospital in the Subcarpathian region of Europe. We reviewed the medical data of 370 patients with confirmed CDI who stayed at the hospital between January 1, 2015, and April 1, 2024. Demographic data, laboratory values, comorbidities, treatments, and clinical outcomes were also collected. We independently compared the data of patients with NTIS and euthyroidism and independently between survivors and nonsurvivors. The statistical test used were Mann-Whitney U-test and Chi-square test (with Pearson's or Yates' correction).
Results:
Of 370 patients, 113 (30%) were included in the study. Eighty-one (71.7%) patients presented with CDI accompanied by NTIS. The median age in both the CDI and NTIS groups was 82 years, and 51.8% of patients were female. NTIS was significantly associated with 3.7-fold higher odds of death compared to euthyroidism (odds ratio = 3.70; 95% confidence interval: 1.02-13.38; P = 0.036). Lower serum free triiodothyronine (FT3) levels were also significantly associated with increased mortality (P = 0.035).
Conclusions:
Low serum FT3 levels appear to be an independent marker of clinical deterioration and a predictor of mortality in patients with CDI and could be incorporated into the prognostic assessment of these patients.
Related Concept Videos
01:30Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
01:17Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
01:25Inflammatory Bowel Disease III: Crohn's Disease
01:20Inflammatory Bowel Disease IV: Clinical Manifestations